KEDRAB is a Intramuscular Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Kedrion Biopharma Inc.. The primary component is Human Rabies Virus Immune Globulin.
| Product ID | 76125-150_5e5c130a-693b-47f9-b44a-3d8f9cde3f98 |
| NDC | 76125-150 |
| Product Type | Plasma Derivative |
| Proprietary Name | KEDRAB |
| Generic Name | Human Rabies Virus Immune Globulin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2017-11-08 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125613 |
| Labeler Name | Kedrion Biopharma Inc. |
| Substance Name | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Active Ingredient Strength | 150 [iU]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-11-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125613 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2017-11-08 |
| Marketing Category | BLA |
| Application Number | BLA125613 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2017-11-08 |
| Marketing Category | BLA |
| Application Number | BLA125613 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2017-11-08 |
| Marketing Category | BLA |
| Application Number | BLA125613 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2017-11-08 |
| Ingredient | Strength |
|---|---|
| HUMAN RABIES VIRUS IMMUNE GLOBULIN | 150 [iU]/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 76125-150 | KEDRAB | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| 49281-190 | IMOGAM RABIES-HT | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KEDRAB 87636954 5623863 Live/Registered |
Kamada Ltd. 2017-10-06 |
![]() KEDRAB 86173344 not registered Dead/Abandoned |
Kamada Ltd. 2014-01-23 |